Evidence map›Paper›PMID 38868415›Full record

ArticlePCN reports : psychiatry and clinical neurosciences2023

Validity and reliability of a computerized cognitive function evaluation battery (CogEvo) as a screening tool.

Yoichi Sawada, Toru Satoh, Hideaki Saba, Hiroshi Kitamoto, Yoshiki Kato, Yoshiko Shiozuka, Tomoko Kuwada, Kana Murakami, Megumi Sasaki, Yudai Abe and 1 more

Abstract read
In one paragraph

Article in PCN reports : psychiatry and clinical neurosciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yoichi SawadaDepartment of Contemporary Welfare, Faculty of Health and Welfare Okayama Prefectural University Soja Okayama Japan.ORCID 0000-0002-6345-382X
Toru SatohDepartment of Neurological Surgery Ryofukai Satoh Neurosurgical Hospital Fukuyama Hiroshima Japan.
Hideaki SabaDepartment of Rehabilitation Ryofukai Satoh Neurosurgical Hospital Fukuyama Hiroshima Japan.
Hiroshi KitamotoDepartment of Rehabilitation Ryofukai Satoh Neurosurgical Hospital Fukuyama Hiroshima Japan.
Yoshiki KatoDepartment of Rehabilitation Ryofukai Satoh Neurosurgical Hospital Fukuyama Hiroshima Japan.
Yoshiko ShiozukaDepartment of Rehabilitation Ryofukai Satoh Neurosurgical Hospital Fukuyama Hiroshima Japan.
Tomoko KuwadaDepartment of Rehabilitation Ryofukai Satoh Neurosurgical Hospital Fukuyama Hiroshima Japan.
Kana MurakamiDepartment of Neurological Surgery Ryofukai Satoh Neurosurgical Hospital Fukuyama Hiroshima Japan.
Megumi SasakiDepartment of Neurological Surgery Ryofukai Satoh Neurosurgical Hospital Fukuyama Hiroshima Japan.
Yudai AbeDepartment of Neurological Surgery Ryofukai Satoh Neurosurgical Hospital Fukuyama Hiroshima Japan.
Kaori HaranoDepartment of Human Welfare, Faculty of Human Relations Otsuma Women's University Chiyoda-ku Tokyo Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: The aim of this study was to determine the validity and reliability of cognitive function evaluation battery, CogEvo, a recently developed computerized cognitive function evaluation battery, as a screening tool for decreased cognitive function. Methods: The study sample comprised 123 (age: 57-97 years) community-dwelling elderly people. They were required to perform five CogEvo tasks and complete two questions-based neuropsychological tests, including the Mini-Mental State Examination, so that the correlations could be analyzed. The validity and reliability of CogEvo were examined using factor analysis, MacDonald's omega reliability coefficient, logistic regression analysis, and receiver operating characteristic curve analysis. Results: Exploratory factor analysis revealed the orientation/spatial cognitive function (orientation and spatial cognition) and attention/executive function (attention, memory, and execution) factors. Structural validity was supported by confirmatory factor analysis. All two-factor-based subtasks showed adequate internal consistency (MacDonald's omega ≥0.6). The total CogEvo score and two-factor scores were significantly correlated with neuropsychological test results. Based on the total CogEvo score, the cognitively normal and cognitive decline groups were identified by receiver operating characteristic curve analysis with a moderate predictive performance. The cognitive decline group was well identified using the orientation/spatial cognitive function factor. Conclusions: CogEvo is a valid and reliable screening tool for cognitive function evaluation. It proved useful in the early identification of cognitive decline in our study sample.

Indexed as

CogEvocognitive declinecomputerized cognitive function evaluation batterydementiavalidity and reliability

Identifiers

PMID38868415
PMCPMC11114302

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.